TrialNeurodegenerative disease management2024

Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures.

Michael R Haupts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.